In contrast, NOD1 expression was markedly decreased in HCC tissues, and overexpression of NOD1 greatly prevented tumorigenesis and increased the response to chemotherapeutic drugs through suppression of the SRC/MAPK pathway in vitro and in vivo [53]. This evidence concerns the gene NOD1 and hepatocellular carcinoma.